{"disease":{"id":"prevention-of-severe-lower-respiratory-tract-disease-caused-by-respiratory-syncytial-virus-rsv-in-young-children-with-a-history-of-premature-birth-or-bronchopulmonary-dysplasia","name":"prevention of severe lower respiratory tract disease caused by respiratory syncytial virus rsv in young children with a history of premature birth or bronchopulmonary dysplasia"},"drugs":{"marketed":[{"drug_id":"rsvpref-vaccine","indication_name":"Prevention of severe lower respiratory tract disease caused by respiratory syncytial virus (RSV) in young children with a history of premature birth or bronchopulmonary dysplasia.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"RSVpreF Vaccine","generic_name":"rsvpref-vaccine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"RSV","drug_class":"vaccine","quality_score":22,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}